About Megnosis
Megnosis is a company based in Daejeon (South Korea) founded in 2020. Megnosis offers products and services including BRAINSPECT20, BRAINCURE20, Reactive EEG, and tCS. Megnosis operates in a competitive market with competitors including ONWARD, Nalu Medical, Atlantic Therapeutics, Synchron and MyndTec, among others.
- Headquarter Daejeon, South Korea
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name (주)메그노시스
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Megnosis
Megnosis offers a comprehensive portfolio of products and services, including BRAINSPECT20, BRAINCURE20, Reactive EEG, and tCS.
Device for EEG-based diagnosis of cognitive disorders like dementia.
Tool for brain stimulation to treat and prevent conditions like depression.
Method for active measurement of brain functions to improve diagnostics.
Transcranial current stimulation for activating brain cells in therapy.
Funding Insights of Megnosis
Detailed funding history for Megnosis
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Megnosis
Investment portfolio details for Megnosis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Megnosis
Detailed financials for Megnosis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Megnosis Comparisons
Peer comparison for Megnosis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Megnosis
Megnosis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ONWARD, Nalu Medical, Atlantic Therapeutics, Synchron and MyndTec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic devices for spinal cord injuries are developed and delivered.
|
|
| Locked | Locked | Locked |
Developer of a neurostimulation system for managing intractable chronic pain
|
|
| Locked | Locked | Locked |
Non-invasive wearable devices for pelvic floor strengthening are developed.
|
|
| Locked | Locked | Locked |
Implantable bioelectronics are developed for neurological condition treatments.
|
|
| Locked | Locked | Locked |
Functional electrical stimulation therapy is developed for upper limb paralysis.
|
|
| Locked | Locked | Locked |
Neuromodulation devices for neurological disorders are developed and offered.
|
Detailed competitors of Megnosis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Megnosis
Complete news archive for Megnosis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Megnosis
Megnosis was founded in 2020.
Megnosis is headquartered in Daejeon, South Korea.
Lee Soon-hyuk is the current CEO of Megnosis.
Megnosis was founded in 2020 in Daejeon, South Korea, within the medical device sector focused on neurology. An EEG-based scalp device is developed to treat dementia symptoms. Brain cells are activated by the device through transcranial electrical stimulation combined with magnetic fields. Operations center on device innovation for symptom alleviation in dementia patients, with activities based in South Korea.
Megnosis's top competitors include ONWARD, Synchron and Nalu Medical.
Megnosis offers BRAINSPECT20, BRAINCURE20, Reactive EEG, and tCS.